Loading…

Study protocol of the Our Futures Vaping Trial: a cluster randomised controlled trial of a school-based eHealth intervention to prevent e-cigarette use among adolescents

Effective and scalable prevention approaches are urgently needed to address the rapidly increasing rates of e-cigarette use among adolescents. School-based eHealth interventions can be an efficient, effective, and economical approach, yet there are none targeting e-cigarettes within Australia. This...

Full description

Saved in:
Bibliographic Details
Published in:BMC public health 2023-04, Vol.23 (1), p.683-12, Article 683
Main Authors: Gardner, Lauren A, Rowe, Amy-Leigh, Stockings, Emily, Champion, Katrina E, Hides, Leanne, McBride, Nyanda, Allsop, Steve, O'Dean, Siobhan, Sunderland, Matthew, Lee, Yong Yi, Mihalopoulos, Cathy, Freeman, Becky, Leung, Janni, McRobbie, Hayden, Stapinski, Lexine, Lee, Nicole, Thornton, Louise, Debenham, Jennifer, Teesson, Maree, Newton, Nicola C
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c564t-ab78b26b3f65af31d35cde301197ccfd37fefa5c1f07562d24a14436d62a88883
cites cdi_FETCH-LOGICAL-c564t-ab78b26b3f65af31d35cde301197ccfd37fefa5c1f07562d24a14436d62a88883
container_end_page 12
container_issue 1
container_start_page 683
container_title BMC public health
container_volume 23
creator Gardner, Lauren A
Rowe, Amy-Leigh
Stockings, Emily
Champion, Katrina E
Hides, Leanne
McBride, Nyanda
Allsop, Steve
O'Dean, Siobhan
Sunderland, Matthew
Lee, Yong Yi
Mihalopoulos, Cathy
Freeman, Becky
Leung, Janni
McRobbie, Hayden
Stapinski, Lexine
Lee, Nicole
Thornton, Louise
Debenham, Jennifer
Teesson, Maree
Newton, Nicola C
description Effective and scalable prevention approaches are urgently needed to address the rapidly increasing rates of e-cigarette use among adolescents. School-based eHealth interventions can be an efficient, effective, and economical approach, yet there are none targeting e-cigarettes within Australia. This paper describes the protocol of the OurFutures Vaping Trial which aims to evaluate the efficacy and cost-effectiveness of the first school-based eHealth intervention targeting e-cigarettes in Australia. A two-arm cluster randomised controlled trial will be conducted among Year 7 and 8 students (aged 12-14 years) in 42 secondary schools across New South Wales, Western Australia and Queensland, Australia. Using stratified block randomisation, schools will be assigned to either the OurFutures Vaping Program intervention group or an active control group (health education as usual). The intervention consists of four web-based cartoon lessons and accompanying activities delivered during health education over a four-week period. Whilst primarily focused on e-cigarette use, the program simultaneously addresses tobacco cigarette use. Students will complete online self-report surveys at baseline, post-intervention, 6-, 12-, 24-, and 36-months after baseline. The primary outcome is the uptake of e-cigarette use at 12-month follow-up. Secondary outcomes include the uptake of tobacco smoking, frequency/quantity of e-cigarettes use and tobacco smoking, intentions to use e-cigarettes/tobacco cigarettes, knowledge about e-cigarettes/tobacco cigarettes, motives and attitudes relating to e-cigarettes, self-efficacy to resist peer pressure and refuse e-cigarettes, mental health, quality of life, and resource utilisation. Generalized mixed effects regression will investigate whether receiving the intervention reduces the likelihood of primary and secondary outcomes. Cost-effectiveness and the effect on primary and secondary outcomes will also be examined over the longer-term. If effective, the intervention will be readily accessible to schools via the OurFutures platform and has the potential to make substantial health and economic impact. Without such intervention, young Australians will be the first generation to use nicotine at higher rates than previous generations, thereby undoing decades of effective tobacco control. The trial has been prospectively registered with the Australian and New Zealand Clinical Trials Registry (ACTRN12623000022662; date registered: 10/01/2023).
doi_str_mv 10.1186/s12889-023-15609-8
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_1a5f725ea95c4d6a8fc7a36eddd524e4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A745366158</galeid><doaj_id>oai_doaj_org_article_1a5f725ea95c4d6a8fc7a36eddd524e4</doaj_id><sourcerecordid>A745366158</sourcerecordid><originalsourceid>FETCH-LOGICAL-c564t-ab78b26b3f65af31d35cde301197ccfd37fefa5c1f07562d24a14436d62a88883</originalsourceid><addsrcrecordid>eNptUstuFDEQHCEQCYEf4IAsceEywY-xPcsFRREhkSLlQOBq9do9u46848X2RMon8Zd4siFkEfbB7XZVtbpdTfOW0WPGevUxM973i5Zy0TKp6KLtnzWHrNOs5Z3snz-JD5pXOd9QynQv-cvmQGjaKc7YYfPrW5ncHdmmWKKNgcSBlDWSqymRs6lMCTP5AVs_rsh18hA-ESA2TLlgIglGFzc-oyM2jiXFEGpYZtgsAyTbdYyhXcIMwXOEUNbEj5V7i2PxcSQl1so43wi21q8gYSlIpowENrEWBRcDZlsB-XXzYoCQ8c3DedR8P_tyfXreXl59vTg9uWytVF1pYan7JVdLMSgJg2BOSOtQUMYW2trBCT3gANKygWqpuOMdsK4TyikOfV3iqLnY6boIN2ab_AbSnYngzX0ippWBVLwNaBjIQXOJsJC2cwr6wWoQCp1zknfYVa3PO63ttNygm_tIEPZE919GvzareGsYpQuqO1EVPjwopPhzwlxMnbjFEGDEOGXDe0oV1wtKK_T9P9CbOKWxzmpGCUplT_Vf1ApqB34cYi1sZ1FzojsplGJyHsLxf1B1O9z4-ts4-JrfI_AdwaaYc8LhsUlGzexWs3OrqW419241M-nd0_E8Uv7YU_wGyXHoCA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2803005807</pqid></control><display><type>article</type><title>Study protocol of the Our Futures Vaping Trial: a cluster randomised controlled trial of a school-based eHealth intervention to prevent e-cigarette use among adolescents</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Gardner, Lauren A ; Rowe, Amy-Leigh ; Stockings, Emily ; Champion, Katrina E ; Hides, Leanne ; McBride, Nyanda ; Allsop, Steve ; O'Dean, Siobhan ; Sunderland, Matthew ; Lee, Yong Yi ; Mihalopoulos, Cathy ; Freeman, Becky ; Leung, Janni ; McRobbie, Hayden ; Stapinski, Lexine ; Lee, Nicole ; Thornton, Louise ; Debenham, Jennifer ; Teesson, Maree ; Newton, Nicola C</creator><creatorcontrib>Gardner, Lauren A ; Rowe, Amy-Leigh ; Stockings, Emily ; Champion, Katrina E ; Hides, Leanne ; McBride, Nyanda ; Allsop, Steve ; O'Dean, Siobhan ; Sunderland, Matthew ; Lee, Yong Yi ; Mihalopoulos, Cathy ; Freeman, Becky ; Leung, Janni ; McRobbie, Hayden ; Stapinski, Lexine ; Lee, Nicole ; Thornton, Louise ; Debenham, Jennifer ; Teesson, Maree ; Newton, Nicola C</creatorcontrib><description>Effective and scalable prevention approaches are urgently needed to address the rapidly increasing rates of e-cigarette use among adolescents. School-based eHealth interventions can be an efficient, effective, and economical approach, yet there are none targeting e-cigarettes within Australia. This paper describes the protocol of the OurFutures Vaping Trial which aims to evaluate the efficacy and cost-effectiveness of the first school-based eHealth intervention targeting e-cigarettes in Australia. A two-arm cluster randomised controlled trial will be conducted among Year 7 and 8 students (aged 12-14 years) in 42 secondary schools across New South Wales, Western Australia and Queensland, Australia. Using stratified block randomisation, schools will be assigned to either the OurFutures Vaping Program intervention group or an active control group (health education as usual). The intervention consists of four web-based cartoon lessons and accompanying activities delivered during health education over a four-week period. Whilst primarily focused on e-cigarette use, the program simultaneously addresses tobacco cigarette use. Students will complete online self-report surveys at baseline, post-intervention, 6-, 12-, 24-, and 36-months after baseline. The primary outcome is the uptake of e-cigarette use at 12-month follow-up. Secondary outcomes include the uptake of tobacco smoking, frequency/quantity of e-cigarettes use and tobacco smoking, intentions to use e-cigarettes/tobacco cigarettes, knowledge about e-cigarettes/tobacco cigarettes, motives and attitudes relating to e-cigarettes, self-efficacy to resist peer pressure and refuse e-cigarettes, mental health, quality of life, and resource utilisation. Generalized mixed effects regression will investigate whether receiving the intervention reduces the likelihood of primary and secondary outcomes. Cost-effectiveness and the effect on primary and secondary outcomes will also be examined over the longer-term. If effective, the intervention will be readily accessible to schools via the OurFutures platform and has the potential to make substantial health and economic impact. Without such intervention, young Australians will be the first generation to use nicotine at higher rates than previous generations, thereby undoing decades of effective tobacco control. The trial has been prospectively registered with the Australian and New Zealand Clinical Trials Registry (ACTRN12623000022662; date registered: 10/01/2023).</description><identifier>ISSN: 1471-2458</identifier><identifier>EISSN: 1471-2458</identifier><identifier>DOI: 10.1186/s12889-023-15609-8</identifier><identifier>PMID: 37046211</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Active control ; Adolescence ; Adolescent ; Adolescents ; Australia ; Cigarettes ; Clinical trials ; Clusters ; E-cigarettes ; Economic impact ; Education ; Effectiveness ; eHealth ; Electronic cigarettes ; Electronic Nicotine Delivery Systems ; Health aspects ; Humans ; Impact analysis ; Intervention ; Mental health ; Prevention ; Public health ; Quality of Life ; Randomization ; Randomized Controlled Trials as Topic ; Schools ; Smoking ; Smoking and youth ; Social aspects ; Students ; Study Protocol ; Teenagers ; Tobacco ; Tobacco smoking ; Vaping ; Vaping - prevention &amp; control</subject><ispartof>BMC public health, 2023-04, Vol.23 (1), p.683-12, Article 683</ispartof><rights>2023. The Author(s).</rights><rights>COPYRIGHT 2023 BioMed Central Ltd.</rights><rights>2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c564t-ab78b26b3f65af31d35cde301197ccfd37fefa5c1f07562d24a14436d62a88883</citedby><cites>FETCH-LOGICAL-c564t-ab78b26b3f65af31d35cde301197ccfd37fefa5c1f07562d24a14436d62a88883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090743/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2803005807?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37046211$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gardner, Lauren A</creatorcontrib><creatorcontrib>Rowe, Amy-Leigh</creatorcontrib><creatorcontrib>Stockings, Emily</creatorcontrib><creatorcontrib>Champion, Katrina E</creatorcontrib><creatorcontrib>Hides, Leanne</creatorcontrib><creatorcontrib>McBride, Nyanda</creatorcontrib><creatorcontrib>Allsop, Steve</creatorcontrib><creatorcontrib>O'Dean, Siobhan</creatorcontrib><creatorcontrib>Sunderland, Matthew</creatorcontrib><creatorcontrib>Lee, Yong Yi</creatorcontrib><creatorcontrib>Mihalopoulos, Cathy</creatorcontrib><creatorcontrib>Freeman, Becky</creatorcontrib><creatorcontrib>Leung, Janni</creatorcontrib><creatorcontrib>McRobbie, Hayden</creatorcontrib><creatorcontrib>Stapinski, Lexine</creatorcontrib><creatorcontrib>Lee, Nicole</creatorcontrib><creatorcontrib>Thornton, Louise</creatorcontrib><creatorcontrib>Debenham, Jennifer</creatorcontrib><creatorcontrib>Teesson, Maree</creatorcontrib><creatorcontrib>Newton, Nicola C</creatorcontrib><title>Study protocol of the Our Futures Vaping Trial: a cluster randomised controlled trial of a school-based eHealth intervention to prevent e-cigarette use among adolescents</title><title>BMC public health</title><addtitle>BMC Public Health</addtitle><description>Effective and scalable prevention approaches are urgently needed to address the rapidly increasing rates of e-cigarette use among adolescents. School-based eHealth interventions can be an efficient, effective, and economical approach, yet there are none targeting e-cigarettes within Australia. This paper describes the protocol of the OurFutures Vaping Trial which aims to evaluate the efficacy and cost-effectiveness of the first school-based eHealth intervention targeting e-cigarettes in Australia. A two-arm cluster randomised controlled trial will be conducted among Year 7 and 8 students (aged 12-14 years) in 42 secondary schools across New South Wales, Western Australia and Queensland, Australia. Using stratified block randomisation, schools will be assigned to either the OurFutures Vaping Program intervention group or an active control group (health education as usual). The intervention consists of four web-based cartoon lessons and accompanying activities delivered during health education over a four-week period. Whilst primarily focused on e-cigarette use, the program simultaneously addresses tobacco cigarette use. Students will complete online self-report surveys at baseline, post-intervention, 6-, 12-, 24-, and 36-months after baseline. The primary outcome is the uptake of e-cigarette use at 12-month follow-up. Secondary outcomes include the uptake of tobacco smoking, frequency/quantity of e-cigarettes use and tobacco smoking, intentions to use e-cigarettes/tobacco cigarettes, knowledge about e-cigarettes/tobacco cigarettes, motives and attitudes relating to e-cigarettes, self-efficacy to resist peer pressure and refuse e-cigarettes, mental health, quality of life, and resource utilisation. Generalized mixed effects regression will investigate whether receiving the intervention reduces the likelihood of primary and secondary outcomes. Cost-effectiveness and the effect on primary and secondary outcomes will also be examined over the longer-term. If effective, the intervention will be readily accessible to schools via the OurFutures platform and has the potential to make substantial health and economic impact. Without such intervention, young Australians will be the first generation to use nicotine at higher rates than previous generations, thereby undoing decades of effective tobacco control. The trial has been prospectively registered with the Australian and New Zealand Clinical Trials Registry (ACTRN12623000022662; date registered: 10/01/2023).</description><subject>Active control</subject><subject>Adolescence</subject><subject>Adolescent</subject><subject>Adolescents</subject><subject>Australia</subject><subject>Cigarettes</subject><subject>Clinical trials</subject><subject>Clusters</subject><subject>E-cigarettes</subject><subject>Economic impact</subject><subject>Education</subject><subject>Effectiveness</subject><subject>eHealth</subject><subject>Electronic cigarettes</subject><subject>Electronic Nicotine Delivery Systems</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Impact analysis</subject><subject>Intervention</subject><subject>Mental health</subject><subject>Prevention</subject><subject>Public health</subject><subject>Quality of Life</subject><subject>Randomization</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Schools</subject><subject>Smoking</subject><subject>Smoking and youth</subject><subject>Social aspects</subject><subject>Students</subject><subject>Study Protocol</subject><subject>Teenagers</subject><subject>Tobacco</subject><subject>Tobacco smoking</subject><subject>Vaping</subject><subject>Vaping - prevention &amp; control</subject><issn>1471-2458</issn><issn>1471-2458</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUstuFDEQHCEQCYEf4IAsceEywY-xPcsFRREhkSLlQOBq9do9u46848X2RMon8Zd4siFkEfbB7XZVtbpdTfOW0WPGevUxM973i5Zy0TKp6KLtnzWHrNOs5Z3snz-JD5pXOd9QynQv-cvmQGjaKc7YYfPrW5ncHdmmWKKNgcSBlDWSqymRs6lMCTP5AVs_rsh18hA-ESA2TLlgIglGFzc-oyM2jiXFEGpYZtgsAyTbdYyhXcIMwXOEUNbEj5V7i2PxcSQl1so43wi21q8gYSlIpowENrEWBRcDZlsB-XXzYoCQ8c3DedR8P_tyfXreXl59vTg9uWytVF1pYan7JVdLMSgJg2BOSOtQUMYW2trBCT3gANKygWqpuOMdsK4TyikOfV3iqLnY6boIN2ab_AbSnYngzX0ippWBVLwNaBjIQXOJsJC2cwr6wWoQCp1zknfYVa3PO63ttNygm_tIEPZE919GvzareGsYpQuqO1EVPjwopPhzwlxMnbjFEGDEOGXDe0oV1wtKK_T9P9CbOKWxzmpGCUplT_Vf1ApqB34cYi1sZ1FzojsplGJyHsLxf1B1O9z4-ts4-JrfI_AdwaaYc8LhsUlGzexWs3OrqW419241M-nd0_E8Uv7YU_wGyXHoCA</recordid><startdate>20230412</startdate><enddate>20230412</enddate><creator>Gardner, Lauren A</creator><creator>Rowe, Amy-Leigh</creator><creator>Stockings, Emily</creator><creator>Champion, Katrina E</creator><creator>Hides, Leanne</creator><creator>McBride, Nyanda</creator><creator>Allsop, Steve</creator><creator>O'Dean, Siobhan</creator><creator>Sunderland, Matthew</creator><creator>Lee, Yong Yi</creator><creator>Mihalopoulos, Cathy</creator><creator>Freeman, Becky</creator><creator>Leung, Janni</creator><creator>McRobbie, Hayden</creator><creator>Stapinski, Lexine</creator><creator>Lee, Nicole</creator><creator>Thornton, Louise</creator><creator>Debenham, Jennifer</creator><creator>Teesson, Maree</creator><creator>Newton, Nicola C</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>M0S</scope><scope>M1P</scope><scope>M7S</scope><scope>PATMY</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230412</creationdate><title>Study protocol of the Our Futures Vaping Trial: a cluster randomised controlled trial of a school-based eHealth intervention to prevent e-cigarette use among adolescents</title><author>Gardner, Lauren A ; Rowe, Amy-Leigh ; Stockings, Emily ; Champion, Katrina E ; Hides, Leanne ; McBride, Nyanda ; Allsop, Steve ; O'Dean, Siobhan ; Sunderland, Matthew ; Lee, Yong Yi ; Mihalopoulos, Cathy ; Freeman, Becky ; Leung, Janni ; McRobbie, Hayden ; Stapinski, Lexine ; Lee, Nicole ; Thornton, Louise ; Debenham, Jennifer ; Teesson, Maree ; Newton, Nicola C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c564t-ab78b26b3f65af31d35cde301197ccfd37fefa5c1f07562d24a14436d62a88883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Active control</topic><topic>Adolescence</topic><topic>Adolescent</topic><topic>Adolescents</topic><topic>Australia</topic><topic>Cigarettes</topic><topic>Clinical trials</topic><topic>Clusters</topic><topic>E-cigarettes</topic><topic>Economic impact</topic><topic>Education</topic><topic>Effectiveness</topic><topic>eHealth</topic><topic>Electronic cigarettes</topic><topic>Electronic Nicotine Delivery Systems</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Impact analysis</topic><topic>Intervention</topic><topic>Mental health</topic><topic>Prevention</topic><topic>Public health</topic><topic>Quality of Life</topic><topic>Randomization</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Schools</topic><topic>Smoking</topic><topic>Smoking and youth</topic><topic>Social aspects</topic><topic>Students</topic><topic>Study Protocol</topic><topic>Teenagers</topic><topic>Tobacco</topic><topic>Tobacco smoking</topic><topic>Vaping</topic><topic>Vaping - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gardner, Lauren A</creatorcontrib><creatorcontrib>Rowe, Amy-Leigh</creatorcontrib><creatorcontrib>Stockings, Emily</creatorcontrib><creatorcontrib>Champion, Katrina E</creatorcontrib><creatorcontrib>Hides, Leanne</creatorcontrib><creatorcontrib>McBride, Nyanda</creatorcontrib><creatorcontrib>Allsop, Steve</creatorcontrib><creatorcontrib>O'Dean, Siobhan</creatorcontrib><creatorcontrib>Sunderland, Matthew</creatorcontrib><creatorcontrib>Lee, Yong Yi</creatorcontrib><creatorcontrib>Mihalopoulos, Cathy</creatorcontrib><creatorcontrib>Freeman, Becky</creatorcontrib><creatorcontrib>Leung, Janni</creatorcontrib><creatorcontrib>McRobbie, Hayden</creatorcontrib><creatorcontrib>Stapinski, Lexine</creatorcontrib><creatorcontrib>Lee, Nicole</creatorcontrib><creatorcontrib>Thornton, Louise</creatorcontrib><creatorcontrib>Debenham, Jennifer</creatorcontrib><creatorcontrib>Teesson, Maree</creatorcontrib><creatorcontrib>Newton, Nicola C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Databases</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Engineering Database</collection><collection>Environmental Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC public health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gardner, Lauren A</au><au>Rowe, Amy-Leigh</au><au>Stockings, Emily</au><au>Champion, Katrina E</au><au>Hides, Leanne</au><au>McBride, Nyanda</au><au>Allsop, Steve</au><au>O'Dean, Siobhan</au><au>Sunderland, Matthew</au><au>Lee, Yong Yi</au><au>Mihalopoulos, Cathy</au><au>Freeman, Becky</au><au>Leung, Janni</au><au>McRobbie, Hayden</au><au>Stapinski, Lexine</au><au>Lee, Nicole</au><au>Thornton, Louise</au><au>Debenham, Jennifer</au><au>Teesson, Maree</au><au>Newton, Nicola C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Study protocol of the Our Futures Vaping Trial: a cluster randomised controlled trial of a school-based eHealth intervention to prevent e-cigarette use among adolescents</atitle><jtitle>BMC public health</jtitle><addtitle>BMC Public Health</addtitle><date>2023-04-12</date><risdate>2023</risdate><volume>23</volume><issue>1</issue><spage>683</spage><epage>12</epage><pages>683-12</pages><artnum>683</artnum><issn>1471-2458</issn><eissn>1471-2458</eissn><abstract>Effective and scalable prevention approaches are urgently needed to address the rapidly increasing rates of e-cigarette use among adolescents. School-based eHealth interventions can be an efficient, effective, and economical approach, yet there are none targeting e-cigarettes within Australia. This paper describes the protocol of the OurFutures Vaping Trial which aims to evaluate the efficacy and cost-effectiveness of the first school-based eHealth intervention targeting e-cigarettes in Australia. A two-arm cluster randomised controlled trial will be conducted among Year 7 and 8 students (aged 12-14 years) in 42 secondary schools across New South Wales, Western Australia and Queensland, Australia. Using stratified block randomisation, schools will be assigned to either the OurFutures Vaping Program intervention group or an active control group (health education as usual). The intervention consists of four web-based cartoon lessons and accompanying activities delivered during health education over a four-week period. Whilst primarily focused on e-cigarette use, the program simultaneously addresses tobacco cigarette use. Students will complete online self-report surveys at baseline, post-intervention, 6-, 12-, 24-, and 36-months after baseline. The primary outcome is the uptake of e-cigarette use at 12-month follow-up. Secondary outcomes include the uptake of tobacco smoking, frequency/quantity of e-cigarettes use and tobacco smoking, intentions to use e-cigarettes/tobacco cigarettes, knowledge about e-cigarettes/tobacco cigarettes, motives and attitudes relating to e-cigarettes, self-efficacy to resist peer pressure and refuse e-cigarettes, mental health, quality of life, and resource utilisation. Generalized mixed effects regression will investigate whether receiving the intervention reduces the likelihood of primary and secondary outcomes. Cost-effectiveness and the effect on primary and secondary outcomes will also be examined over the longer-term. If effective, the intervention will be readily accessible to schools via the OurFutures platform and has the potential to make substantial health and economic impact. Without such intervention, young Australians will be the first generation to use nicotine at higher rates than previous generations, thereby undoing decades of effective tobacco control. The trial has been prospectively registered with the Australian and New Zealand Clinical Trials Registry (ACTRN12623000022662; date registered: 10/01/2023).</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>37046211</pmid><doi>10.1186/s12889-023-15609-8</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2458
ispartof BMC public health, 2023-04, Vol.23 (1), p.683-12, Article 683
issn 1471-2458
1471-2458
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_1a5f725ea95c4d6a8fc7a36eddd524e4
source Publicly Available Content Database; PubMed Central
subjects Active control
Adolescence
Adolescent
Adolescents
Australia
Cigarettes
Clinical trials
Clusters
E-cigarettes
Economic impact
Education
Effectiveness
eHealth
Electronic cigarettes
Electronic Nicotine Delivery Systems
Health aspects
Humans
Impact analysis
Intervention
Mental health
Prevention
Public health
Quality of Life
Randomization
Randomized Controlled Trials as Topic
Schools
Smoking
Smoking and youth
Social aspects
Students
Study Protocol
Teenagers
Tobacco
Tobacco smoking
Vaping
Vaping - prevention & control
title Study protocol of the Our Futures Vaping Trial: a cluster randomised controlled trial of a school-based eHealth intervention to prevent e-cigarette use among adolescents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T07%3A33%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Study%20protocol%20of%20the%20Our%20Futures%20Vaping%20Trial:%20a%20cluster%20randomised%20controlled%20trial%20of%20a%20school-based%20eHealth%20intervention%20to%20prevent%20e-cigarette%20use%20among%20adolescents&rft.jtitle=BMC%20public%20health&rft.au=Gardner,%20Lauren%20A&rft.date=2023-04-12&rft.volume=23&rft.issue=1&rft.spage=683&rft.epage=12&rft.pages=683-12&rft.artnum=683&rft.issn=1471-2458&rft.eissn=1471-2458&rft_id=info:doi/10.1186/s12889-023-15609-8&rft_dat=%3Cgale_doaj_%3EA745366158%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c564t-ab78b26b3f65af31d35cde301197ccfd37fefa5c1f07562d24a14436d62a88883%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2803005807&rft_id=info:pmid/37046211&rft_galeid=A745366158&rfr_iscdi=true